Cover Image

Prognosis and staging of AL amyloidosis

The treatment options for systemic light chain amyloidosis (AL) are currently widening in an unprecedented way, brought about by an expanding arsenal of anti-myeloma therapy as well as by novel approaches to target toxic light chains and, most recently, deposited amyloid directly. In this context, a...

Full description

Saved in:
Bibliographic Details
Main Authors: Dittrich, Tobias (Author) , Kimmich, Christoph (Author) , Hegenbart, Ute (Author) , Schönland, Stefan (Author)
Format: Article (Journal)
Language:English
Published: June 22, 2020
In: Acta haematologica
Year: 2020, Volume: 143, Issue: 4, Pages: 388-400
ISSN:1421-9662
DOI:10.1159/000508287
Online Access:Verlag, Volltext: https://doi.org/10.1159/000508287
Verlag, Volltext: https://www.karger.com/Article/FullText/508287
Get full text
Author Notes:Tobias Dittrich, Christoph Kimmich, Ute Hegenbart, Stefan O. Schönland

MARC

LEADER 00000caa a2200000 c 4500
001 173052043X
003 DE-627
005 20230426165530.0
007 cr uuu---uuuuu
008 200911s2020 xx |||||o 00| ||eng c
024 7 |a 10.1159/000508287  |2 doi 
035 |a (DE-627)173052043X 
035 |a (DE-599)KXP173052043X 
035 |a (OCoLC)1341359336 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Dittrich, Tobias  |d 1986-  |e VerfasserIn  |0 (DE-588)1075743141  |0 (DE-627)833664085  |0 (DE-576)444611495  |4 aut 
245 1 0 |a Prognosis and staging of AL amyloidosis  |c Tobias Dittrich, Christoph Kimmich, Ute Hegenbart, Stefan O. Schönland 
264 1 |c June 22, 2020 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 11.09.2020 
520 |a The treatment options for systemic light chain amyloidosis (AL) are currently widening in an unprecedented way, brought about by an expanding arsenal of anti-myeloma therapy as well as by novel approaches to target toxic light chains and, most recently, deposited amyloid directly. In this context, accurate estimates of prognosis in AL, which allow for reliable patient advice and for example comparison of different therapies, are particularly important to clinicians. Some biomarkers and especially the genetic background of the underlying clonal disease as evaluated by interphase fluorescence in situ hybridization even have predictive value, enabling an appropriate treatment selection. Derived from the most frequently involved organs in AL, heart and kidney, this review focuses on overall survival and renal survival. A comprehensive overview and summary of reported prognostic factors and biomarkers in AL is given and the most important and validated factors are highlighted. Finally, established staging systems in AL as well as validated and perspective response criteria are presented. 
700 1 |a Kimmich, Christoph  |e VerfasserIn  |0 (DE-588)1075478413  |0 (DE-627)833305042  |0 (DE-576)443499632  |4 aut 
700 1 |a Hegenbart, Ute  |e VerfasserIn  |0 (DE-588)1028373708  |0 (DE-627)73062157X  |0 (DE-576)35901903X  |4 aut 
700 1 |a Schönland, Stefan  |d 1969-  |e VerfasserIn  |0 (DE-588)122405226  |0 (DE-627)705896137  |0 (DE-576)293255792  |4 aut 
773 0 8 |i Enthalten in  |t Acta haematologica  |d Basel : Karger, 1948  |g 143(2020), 4, Seite 388-400  |w (DE-627)300188080  |w (DE-600)1481888-7  |w (DE-576)252619641  |x 1421-9662  |7 nnas  |a Prognosis and staging of AL amyloidosis 
773 1 8 |g volume:143  |g year:2020  |g number:4  |g pages:388-400  |g extent:12  |a Prognosis and staging of AL amyloidosis 
856 4 0 |u https://doi.org/10.1159/000508287  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://www.karger.com/Article/FullText/508287  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20200911 
993 |a Article 
994 |a 2020 
998 |g 122405226  |a Schönland, Stefan  |m 122405226:Schönland, Stefan  |d 910000  |d 910100  |e 910000PS122405226  |e 910100PS122405226  |k 0/910000/  |k 1/910000/910100/  |p 4  |y j 
998 |g 1028373708  |a Hegenbart, Ute  |m 1028373708:Hegenbart, Ute  |d 910000  |d 910100  |e 910000PH1028373708  |e 910100PH1028373708  |k 0/910000/  |k 1/910000/910100/  |p 3 
998 |g 1075478413  |a Kimmich, Christoph  |m 1075478413:Kimmich, Christoph  |d 910000  |d 910100  |e 910000PK1075478413  |e 910100PK1075478413  |k 0/910000/  |k 1/910000/910100/  |p 2 
998 |g 1075743141  |a Dittrich, Tobias  |m 1075743141:Dittrich, Tobias  |d 910000  |d 910100  |e 910000PD1075743141  |e 910100PD1075743141  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN173052043X  |e 3750221006 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"doi":["10.1159/000508287"],"eki":["173052043X"]},"relHost":[{"id":{"eki":["300188080"],"issn":["1421-9662"],"zdb":["1481888-7"]},"part":{"text":"143(2020), 4, Seite 388-400","issue":"4","year":"2020","pages":"388-400","volume":"143","extent":"12"},"recId":"300188080","language":["eng"],"disp":"Prognosis and staging of AL amyloidosisActa haematologica","type":{"bibl":"periodical","media":"Online-Ressource"},"title":[{"title_sort":"Acta haematologica","title":"Acta haematologica"}],"pubHistory":["1.1948 -"],"origin":[{"publisher":"Karger","dateIssuedKey":"1948","dateIssuedDisp":"1948-","publisherPlace":"Basel"}],"note":["Gesehen am 04.04.2019"]}],"recId":"173052043X","name":{"displayForm":["Tobias Dittrich, Christoph Kimmich, Ute Hegenbart, Stefan O. Schönland"]},"physDesc":[{"extent":"12 S."}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 11.09.2020"],"origin":[{"dateIssuedDisp":"June 22, 2020","dateIssuedKey":"2020"}],"title":[{"title":"Prognosis and staging of AL amyloidosis","title_sort":"Prognosis and staging of AL amyloidosis"}],"language":["eng"],"person":[{"display":"Dittrich, Tobias","family":"Dittrich","role":"aut","given":"Tobias"},{"display":"Kimmich, Christoph","family":"Kimmich","role":"aut","given":"Christoph"},{"display":"Hegenbart, Ute","family":"Hegenbart","given":"Ute","role":"aut"},{"display":"Schönland, Stefan","family":"Schönland","given":"Stefan","role":"aut"}]} 
SRT |a DITTRICHTOPROGNOSISA2220 

Similar Items